The challenges and opportunities of conducting a clinical trial in a low resource setting: The case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial

Trials

Volumn 12, Issue , 2011, Pages

  Mbuagbaw, Lawrence ^a   Thabane, Lehana ^b,c   Ongolo Zogo, Pierre ^a   Lang, Trudie ^d  

^a YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMEROON MOBILE PHONE SMS TRIAL; CLINICAL RESEARCH; COMPENSATION; DEVELOPING COUNTRY; HEALTH CARE FINANCING; HEALTH CARE PERSONNEL; HUMAN; INFORMED CONSENT; INTERVIEW; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MOBILE PHONE; NOTE; POPULATION RESEARCH; SOCIOECONOMICS; ATTITUDE TO HEALTH; CAMEROON; CLINICAL COMPETENCE; CLINICAL TRIAL; COMMUNICATION DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURAL FACTOR; ECONOMICS; EDITORIAL; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEALTH PERSONNEL ATTITUDE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ANTIRETROVIRUS AGENT;

ANTI-RETROVIRAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; CAMEROON; CELLULAR PHONE; CLINICAL COMPETENCE; COMMUNICATION BARRIERS; COMPENSATION AND REDRESS; CULTURAL CHARACTERISTICS; DEVELOPING COUNTRIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INFORMED CONSENT; LANGUAGE; MEDICATION ADHERENCE; ORGANIZATIONAL OBJECTIVES; PATIENT SELECTION; RESEARCH SUPPORT AS TOPIC; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS;

EID: 79958033265     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-145     Document Type: Note

References (33)

1. Domanski MJ, McKinlay S. Successful randomized trials: a handbook for the 21st century. 2009, Philadelphia: Lippincott Williams & Wilkins.
2. The Cochrane Collaboration Accessed, February 26, 2011, The Cochrane Collaboration., http://www.cochrane.org
3. Clinicaltrials.gov Accessed, October 28, 2010, Clinicaltrials.gov., http://www.clinicaltrials.gov
4. The WHO ICTRP Accessed February 6, 2011, The WHO ICTRP., http://www.who.int/ictrp/en/
5. Devasenapathy N, Singh K, Prabhakaran D. Conduct of clinical trials in developing countries: a perspective. Curr Opin Cardiol 2009, 24(4):295-300. 10.1097/HCO.0b013e32832af21b, 19444095.
6. Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, Fitzpatrick R, Angus BJ, Denis E, Merson L, Cheah PY, Chilengi R, Kimutai R, Marsh K. Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis 2010, 29(6):e619.
7. Hayasaka E. Approaches Vary for Clinical Trials in Developing Countries. J Natl Cancer Inst Monogr 2005, 97(19):1401-1403.
8. Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 2001, 345(2):139-142. 10.1056/NEJM200107123450212, 11450665.
9. Schuklenk U. For-Profit Clinical Trials in Developing Countries--Those Troublesome Patient Benefits. Am J Bioeth 2010, 10(6):52-54. 10.1080/15265161.2010.483183, 20818562.
10. Howie S. Conduct of clinical trials in developing countries. Lancet 2007, 18(9587):562. 370.
11. Miran E. Clinical trials in the developing world. Lancet 2007, 369(9576):1859.
12. Beran RG. The ethics of clinical research and the conduct of drug trials: International comparisons and codes of conduct. Med Law 2000, 19:501-21.
13. Global Health Clinical Trials Accessed June 9, 2011, Global Health Clinical Trials., http://ght.globalhealthehub.org/
14. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester R, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougoui RC, Mba R, Ndongo JS, Nkoa FC, Atangana Ondoa H. The Cameroon Mobile Phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials 2011, 12(1):5. 10.1186/1745-6215-12-5, 3023676, 21211064.
15. UNICEF Cameroon statistics Accessed April 11, 2011. , UNICEF Cameroon statistics., http://www.unicef.org/infobycountry/cameroon_statistics.html
16. World Health Organization Yaoundé, Cameroon-HUG, Switzerland. 2010, Accessed April 11, 2011. , World Health Organization., http://www.who.int/patientsafety/implementation/apps/first_wave/cameroon_hug/en/index.html
17. Lewis MP. Ethnologue: Languages of the World, Sixteenth edition. Dallas, Texas: SIL International. 2009, Accessed April 11, 2011. ., http://www.ethnologue.com/
18. Antes G. The new CONSORT statement. BMJ 2010, 340:c1432. 10.1136/bmj.c1432, 20332507.
19. Lorenzo C, Garrafa V, Solbakk JH, Vidal S. Hidden risks associated with clinical trials in developing countries. J Med Ethics 2010, 36:111-115. 10.1136/jme.2009.031708, 20133407.
20. Holtedahl K, Bonono L, Salpou D. The value of population campaigns offering free-of-charge HIV-testing: Observational study in a town in Cameroon. Nor epidemiol 2005, 15:159-164.
21. Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, Raj T, D'Souza G, De Costa A. Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav 2010, 14:716-720. 10.1007/s10461-009-9658-3, 20054634.
22. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Guideline for Good Clinical Practice E6 (R1) Accessed December 12, 2010, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Guideline for Good Clinical Practice E6 (R1)., http://ichgcp.net/
23. Grimes DA, Hubacher D, Nanda K, Schulz KF, Moher D, Altman DG. The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet 2005, 366(9480):172-174. 10.1016/S0140-6736(05)66875-4, 16005342.
24. Lang T, Cheah PY, White NJ, . Clinical research time for globally sensible guidelines. Lancet 2011, in Press., Clinical research.
25. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376(9734):23-32. CRASH-2 trial collaborators.
26. WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human subjects. Accessed February 6, 2011, WMA., http://www.wma.net/en/30publications/10policies/b3/index.html
27. The CONSORT Statement Accessed February 6, 2011, The CONSORT Statement., http://www.consort-statement.org/consort-statement/
28. Kilama WL, Chilengi R, Wanga CL. Towards an African-driven malaria vaccine development program: history and activities of the African Malaria Network Trust (AMANET). Am J Trop Med Hyg 2007, 77(6):282-288.
29. Greenwood BM, Bhasin A, Bowler CH, Naylor H, Targett GA. Capacity strengthening in malaria research: the Gates Malaria Partnership. Trends Parasitol 2006, 22(7):278-284. 10.1016/j.pt.2006.05.005, 16725373.
30. Kitua AY, Corrah T, Herbst K, Nyirenda T, Agwale S, Makanga M, Mgone CS. Strengthening capacity, collaboration and quality of clinical research in Africa: EDCTP Networks of Excellence. Tanzan J Health Res 2009, 11(1):51-54.
31. Shafiq N, Pandhi P, Malhotra S. Investigator-initiated pragmatic trials in developing countries - much needed but much ignored. Br J Clin Pharmacol 2009, 67(1):141-2. 10.1111/j.1365-2125.2008.03291.x, 2668099, 19006544.
32. Kasper CK. Conduct of clinical trials in developing countries. Haemophilia 2002, 8:166-169. 10.1046/j.1365-2516.2002.00594.x, 12010405.
33. Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med 1997, 337:1003-5. 10.1056/NEJM199710023371411, 9309109.